RXRX gears up for Q4 with $25.5 million revenue view as investors eye pipeline updates and REC-4881 progress ahead of FDA ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of ...

Is On Investors’ Radar Today Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt ...

It's a potential game-changing technology. The company just needs to prove to the world that it works well enough.

Last year's weakness is ultimately an improved entry opportunity for long-term-minded investors.

Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER, BC, Jan. 29, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary – The global AI medical imaging market exploded to a staggering $2.57 ...

A bug report was uploaded including screen recordings from the upcoming Aluminium OS. A bug report was uploaded including screen recordings from the upcoming Aluminium OS. is a news editor with over ...

A leaked bug report gives more info on Google's new OS. Aluminium OS will be the merging of Android and ChromeOS. The new OS should be released sometime this year. Google's plan to merge ChromeOS and ...

With over a decade of experience reporting on consumer technology, James covers mobile phones, apps, operating systems, wearables, AI, and more.

Multi-OS devices are finally becoming viable as Google, Microsoft, and Lenovo rethink how operating systems coexist across modern hardware. image: envato/melis82 The tech world has seen its share of ...